Why it matters nowTularemia is classified as a CDC Category A bioterrorism agent due to extreme virulence (infection possible with as few as 10 cells) and 30% mortality in untreated cases. The documented re-emergence across multiple Northern Hemisphere regions underscores the need for updated clinical awareness and early diagnostic capacity.
Why it matters nowThe convergence of resistance, hypervirulence, and potential vaccine escape within a dominant lineage is framed by the authors as grounds to revisit antibiotic stewardship and pertussis vaccination strategies.
Why it matters nowThe registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.